Pharmalucence, Inc. has recalled 95 kits of Technetium Tc99m Medronate, a diagnostic drug used for bone imaging, because of a reported breach of sterility. The recall affects both 5-count boxes (NDC 45567-0040-1) and 30-count boxes (NDC 45567-0040-2) from lot 4223. A lack of sterility in an injectable medication can lead to serious, life-threatening infections if the product is contaminated. This product was distributed nationwide to healthcare facilities. Patients who may have received this medication should contact their healthcare provider or pharmacist, as the sterility of the product cannot be guaranteed.
A breach of sterility means the drug may be contaminated with microorganisms like bacteria or fungi. Because this medication is injected directly into the body, any contamination poses a significant risk of causing serious infections or sepsis.
Healthcare provider guidance and product refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.